Ceramides as modulators of cellular and whole-body metabolism.
Explore this paper's citation graph
Summary
In both cell-autonomous systems and complex organisms, ceramides modify intracellular signaling pathways to slow anabolism, ensuring that catabolism ensues, and these ceramide actions have important implications for diseases associated with obesity.
- Type
- review
- Published
- 2011-11-01
- Cited by
- 421
- References
- 132
- Access
- Open access
- OpenAlex
- https://openalex.org/W2001312856
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:22200523
Keywords
Ceramide, Sphingolipid, Anabolism, Catabolism, Intracellular
References
- Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells.
- Is Autophagy the Key Mechanism by Which the Sphingolipid Rheostat Controls the Cell Fate Decision?
- Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin Resistance
- The many ways to regulate glucose transporter 4.
- Involvement of mitochondrial contact sites in the subcellular compartmentalization of phospholipid biosynthetic enzymes.
- Ceramide activates heterotrimeric protein phosphatase 2A.
- LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice.
- Hypothalamic insulin signaling is required for inhibition of glucose production
- Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity
- Palmitate Inhibition of Insulin Gene Expression Is Mediated at the Transcriptional Level via Ceramide Synthesis*
- Reactive oxygen species have a causal role in multiple forms of insulin resistance
- Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice
- Akt activity in Alzheimer's disease and other neurodegenerative disorders
- Ceramide down‐regulates System A amino acid transport and protein synthesis in rat skeletal muscle cells
- Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death.
- Ceramide: a common pathway for atherosclerosis?
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
- Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide.
- Partial purification and characterization of sphingosine N-acyltransferase (ceramide synthase) from bovine liver mitochondrion-rich fraction
- Akt like a woman: gender differences in susceptibility to cardiovascular disease.
Cited by
- Cardiac Metabolism in Heart Failure - Implications beyond ATP production
- SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes[S]
- De Novo Lipogenesis Products and Endogenous Lipokines
- Evolution of Membrane Bound Proteins and their Ligands : The Melanocortin (MC) Receptor Inverse Agonists AgRP2, ASIP2, Drug/Metabolite Transporters, and SPNS1
- Fatty acids, monocytes and ageing
- The Role of Receptors for Advanced Glycation End-Products (RAGE) and Ceramide in Cardiovascular Disease
- Modulation of skeletal muscle insulin sensitivity and SNAT2 amino acid transporter expression by fatty acid availability
- Lipid-mediated muscle insulin resistance: different fat, different pathways?
- Safety and risk assessment of ceramide 3 in cosmetic products.
- Glucose and lipid metabolism in human skeletal muscle
- The Role of Ceramides in Mediating Endotoxin-Induced Mitochondrial Disruption
- The effect of short‐term overfeeding on serum lipids in healthy humans
- Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome
- Dihydroceramides: From Bit Players to Lead Actors*
- Insulin resistance in clinical and experimental alcoholic liver disease
- Role of acid sphingomyelinase bioactivity in human CD4+ T-cell activation and immune responses
- TOR complex 2 regulates plasma membrane homeostasis
- Transcriptional and Post-transcriptional Regulation of Hepcidin and Iron Metabolism by Lipid Signaling in the Liver
- Functional inhibitors of acid sphingomyelinase (FIASMAs).
- Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide*
Related papers
- The long and the short of ceramides
- Ceramide Transfer Protein and Cancer
- Ceramide synthases as potential targets for therapeutic intervention in human diseases.
- Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease
- High fat diet induces ceramide and sphingomyelin formation in rat’s liver nuclei
- Ceramide function in the brain: when a slight tilt is enough
- Ceramide synthase.
- Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.